PCR identification of Mycobacterium bovis BCG

被引：141
|
作者：
Talbot, EA
Williams, DL
Frothingham, R
机构：
[1] VET AFFAIRS MED CTR, INFECT DIS SECT, DURHAM, NC 27705 USA
[2] DUKE UNIV, MED CTR, DEPT MED, DIV INFECT DIS & INT HLTH, DURHAM, NC 27710 USA
[3] LOUISIANA STATE UNIV, GW LONG HANSENS DIS CTR, LAB RES BRANCH, MOL BIOL RES DEPT, BATON ROUGE, LA 70803 USA
来源：
JOURNAL OF CLINICAL MICROBIOLOGY | 1997年 / 35卷 / 03期
关键词：
D O I：
10.1128/JCM.35.3.566-569.1997
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The attenuated bacillus Calmette-Guerin (BCG) vaccine strain is derived from a virulent strain of Mycobacterium bovis. BCG is difficult to differentiate from other strains of M. bovis and other members of the M. tuberculosis complex by conventional methods. Recently, a genomic region designated RD1 was found to be present in all virulent M. bovis and M. tuberculosis strains tested but deleted from all BCG strains tested. With this information, a multiplex PCR method was developed to detect the RD1 deletion. A large collection of BCG and other M. tuberculosis complex strains from diverse host and geographic origins was tested. RD1 was deleted in 23 of 23 BCG strains. RD1 was present in 129 of 129 other M. tuberculosis complex strains. This multiplex PCR method can be used as a tool for the rapid and specific identification of BCG.
引用
收藏
页码：566 / 569
页数：4
相关论文
共 50 条
  • [21] MYCOBACTERIUM-BOVIS (BCG) VACCINATION - REPLY
    LUMB, R
    SHAW, D
    MEDICAL JOURNAL OF AUSTRALIA, 1992, 156 (11) : 812 - 812
  • [22] Cytotoxic activity induced by Mycobacterium bovis BCG
    Gheorghiu, M
    Lagranderie, M
    Balazuc, AM
    Gicquel, B
    MODULATION OF THE IMMUNE RESPONSE TO VACCINE ANTIGENS, 1998, 92 : 199 - 208
  • [23] Survival of Mycobacterium tuberculosis and Mycobacterium bovis BCG in lysosomes in vivo
    Sundaramurthy, Varadharajan
    Korf, Hannelie
    Singla, Ashima
    Scherr, Nicole
    Nguyen, Liem
    Ferrari, Giorgio
    Landmann, Regine
    Huygen, Kris
    Pieters, Jean
    MICROBES AND INFECTION, 2017, 19 (11) : 515 - 526
  • [24] Mycobacterium bovis BCG binds factor H
    Aziz, M. Abdul
    Carroll, M.
    Sim, R. B.
    Sim, E.
    IMMUNOLOGY, 2011, 135 : 86 - 86
  • [25] Auxotrophic Mycobacterium bovis BCG: Updates and Perspectives
    Dellagostin, Odir Antonio
    Borsuk, Sibele
    Oliveira, Thais Larre
    Seixas, Fabiana Kommling
    VACCINES, 2022, 10 (05)
  • [26] Mycobacterium bovis BCG in metastatic melanoma therapy
    Martha Lucia Ruiz Benitez
    Camila Bonnemann Bender
    Thaís Larré Oliveira
    Kyle M. Schachtschneider
    Tiago Collares
    Fabiana Kömmling Seixas
    Applied Microbiology and Biotechnology, 2019, 103 : 7903 - 7916
  • [27] Immunosorbents for the preparation of Mycobacterium bovis BCG antigen
    Krejcikova, S
    Benes, MJ
    Wisingerova, E
    Turkova, J
    COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 1996, 61 (12) : 1823 - 1830
  • [28] Mycobacterium bovis BCG in metastatic melanoma therapy
    Ruiz Benitez, Martha Lucia
    Bender, Camila Bonnemann
    Oliveira, Thais Larre
    Schachtschneider, Kyle M.
    Collares, Tiago
    Seixas, Fabiana Koemmling
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2019, 103 (19) : 7903 - 7916
  • [29] PURIFICATION, CHARACTERIZATION AND IDENTIFICATION OF A 32 KDA PROTEIN ANTIGEN OF MYCOBACTERIUM-BOVIS BCG
    DEBRUYN, J
    HUYGEN, K
    BOSMANS, R
    FAUVILLE, M
    LIPPENS, R
    VANVOOREN, JP
    FALMAGNE, P
    WECKX, M
    WIKER, HG
    HARBOE, M
    TURNEER, M
    MICROBIAL PATHOGENESIS, 1987, 2 (05) : 351 - 366
  • [30] Mycobacterium bovis BCG vertebral osteomyelitis after intravesical BCG therapy, diagnosed by PCR-based genomic deletion analysis
    Nikaido, Takuya
    Ishibashi, Kei
    Otani, Koji
    Yabuki, Shoji
    Konno, Shinichi
    Mori, Shuichi
    Ohashi, Kazutaka
    Ishida, Takashi
    Nakano, Michiko
    Yamaguchi, Osamu
    Suzutani, Tatsuo
    Kikuchi, Shinichi
    JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (12) : 4085 - 4087
12345